Showing results (191-200 of 658) with videos related to
Sort By:
Pageof 66
Journal of Neurosurgery|January 26, 2024
The AANS/CNS Section on Tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumorsIan F Parney, Ronald E Warnick, Frederick F Lang, et al.Journal of Neuro-Oncology|November 1, 2014
Symptoms and socio-economic impact of ependymoma on adult patients: results of the Adult Ependymoma Outcomes Project 2Tobias Walbert, Tito R Mendoza, Elizabeth Vera-Bolaños, et al.Neuro-Oncology|April 22, 2010
Genetic variants in inflammation pathway genes and asthma in glioma susceptibilityE Amirian, Yanhong Liu, Michael E Scheurer, et al.Journal of Neuro-Oncology|March 26, 2013
Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomideNicole A Shonka, Brett Theeler, Daniel Cahill, et al.Neuro-Oncology|August 21, 2015
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptomsTerri S Armstrong, Elizabeth Vera-Bolanos, Alvina A Acquaye, et al.International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastasesUgur Selek, Eric L Chang, Samuel J Hassenbusch, et al.Journal of Neurosurgery|March 24, 2009
Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complicationsBrian J Williams, Dima Suki, Benjamin D Fox, et al.Journal of Neuro-Oncology|December 6, 2006
GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trialsSusan Chang, Michael Vogelbaum, Frederick F Lang, et al.AJNR. American Journal of Neuroradiology|July 1, 2025
State of Practice: A Report from the Inaugural SNIS Neurointerventional Oncology SummitChristopher C Young, Kazim H Narsinh, Stephen R Chen, et al.Neuro-Oncology|July 14, 2021
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stressPratibha Sharma, Jihong Xu, Katie Williams, et al.Pageof 66